Phase I Clinical Study on the Safety, Tolerance, Efficacy and Pharmacokinetics of Repeated Intratympanic HY01 in Patients With Sudden Sensorineural Hearing Loss
Latest Information Update: 06 Jun 2023
At a glance
- Drugs Minocycline (Primary)
- Indications Sensorineural hearing loss
- Focus Adverse reactions
- Sponsors Heyu (Suzhou) Pharmaceutical Technology
- 21 Jul 2021 New trial record